Benzinga: DEA’s Case For Scheduling Psychedelics Challenged In Landmark Hearing

The DOI and DOC ban case has reached the hearing stage, the first since MDMA was added to Schedule I in the 1980s. While the hearing focuses on these two substances, it also raises broader questions about drug criminalization and the DEA’s authority. As the hearing enters its second week, defenders remain hopeful, with a […]